DE3877904D1 - Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. - Google Patents

Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.

Info

Publication number
DE3877904D1
DE3877904D1 DE8888117902T DE3877904T DE3877904D1 DE 3877904 D1 DE3877904 D1 DE 3877904D1 DE 8888117902 T DE8888117902 T DE 8888117902T DE 3877904 T DE3877904 T DE 3877904T DE 3877904 D1 DE3877904 D1 DE 3877904D1
Authority
DE
Germany
Prior art keywords
azelastin
nose
eye
contain
products containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8888117902T
Other languages
German (de)
English (en)
Inventor
Helmut Dr Hettche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340483&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3877904(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Priority to DE8888117902T priority Critical patent/DE3877904D1/de
Application granted granted Critical
Publication of DE3877904D1 publication Critical patent/DE3877904D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE8888117902T 1987-11-13 1988-10-27 Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. Revoked DE3877904D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8888117902T DE3877904D1 (de) 1987-11-13 1988-10-27 Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3738681 1987-11-13
DE8888117902T DE3877904D1 (de) 1987-11-13 1988-10-27 Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.

Publications (1)

Publication Number Publication Date
DE3877904D1 true DE3877904D1 (de) 1993-03-11

Family

ID=6340483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888117902T Revoked DE3877904D1 (de) 1987-11-13 1988-10-27 Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.

Country Status (15)

Country Link
US (1) US5164194A (enExample)
EP (1) EP0316633B1 (enExample)
JP (3) JP2911460B2 (enExample)
AT (1) ATE84968T1 (enExample)
AU (1) AU613107B2 (enExample)
CA (1) CA1319322C (enExample)
DE (1) DE3877904D1 (enExample)
DK (1) DK174928B1 (enExample)
ES (1) ES2053678T3 (enExample)
GR (1) GR3007202T3 (enExample)
IE (1) IE61562B1 (enExample)
NL (1) NL990011I1 (enExample)
PT (1) PT88985B (enExample)
YU (1) YU46988B (enExample)
ZA (1) ZA888461B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051726T3 (es) * 1987-01-17 1994-07-01 Asta Medica Ag Procedimiento para preparar productos inyectables que contienen azelastin y teofilina o azelastin y beta-mimeticos.
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP4138910B2 (ja) 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
DE20009841U1 (de) * 2000-05-31 2001-10-25 Phyt-Immun GmbH, 66424 Homburg Nasensalbe auf Basis von Vaselin
JP3450805B2 (ja) 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
AU2002236781A1 (en) * 2001-01-18 2002-07-30 Medpointe Healthcare Inc. Treatment for snoring
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2495830C (en) 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) * 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US7378082B1 (en) * 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
BRPI0821647A2 (pt) * 2007-12-21 2015-06-16 Schering Plough Healthcare Realce da fotosestabillização de oximetazolina
US8642069B2 (en) * 2008-08-27 2014-02-04 Alexander D. Goldin Composition and method for treating colds
KR101261230B1 (ko) 2010-11-29 2013-05-07 한림제약(주) 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
EP2968323A4 (en) 2013-03-13 2016-12-14 Flatley Discovery Lab PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
ES2937145T3 (es) * 2020-05-29 2023-03-24 CEBINA GmbH Azelastina como tratamiento antiviral
AU2021291684A1 (en) 2020-06-15 2022-12-08 Alkem Laboratories Limited Combination of alcaftadine and a corticosteroid
US20240173331A1 (en) 2021-04-01 2024-05-30 Alkem Laboratories Limited Nasal compositions comprising alcaftadine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US158564A (en) * 1875-01-12 Improvement in medicine-droppers
US2119643A (en) * 1934-11-07 1938-06-07 Mendl Viktor Pressure-operated diffuser of toilet-liquids
US2136940A (en) * 1936-07-02 1938-11-15 Aromel Corp Atomizer
US2457024A (en) * 1945-02-13 1948-12-21 Arp Claus Collapsible tube holder
US2995308A (en) * 1958-09-23 1961-08-08 American Home Prod Jet stream dispenser
CH572914A5 (enExample) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate
US4769369A (en) * 1986-11-14 1988-09-06 Pennwalt Corporation Anti-allergy 1(2H)-phthalazinones
JP6034925B2 (ja) 2015-07-07 2016-11-30 株式会社ブリヂストン 接着剤組成物、接着剤被覆繊維、ゴム物品及び空気入りタイヤ

Also Published As

Publication number Publication date
JPH11349484A (ja) 1999-12-21
ZA888461B (en) 1989-08-30
EP0316633B1 (de) 1993-01-27
DK630188A (da) 1989-05-14
DK630188D0 (da) 1988-11-11
AU2506388A (en) 1989-05-18
ES2053678T3 (es) 1994-08-01
ATE84968T1 (de) 1993-02-15
GR3007202T3 (enExample) 1993-07-30
JPH01153639A (ja) 1989-06-15
PT88985A (pt) 1988-12-01
JP2911460B2 (ja) 1999-06-23
IE883403L (en) 1989-05-13
YU209288A (en) 1990-04-30
US5164194A (en) 1992-11-17
CA1319322C (en) 1993-06-22
DK174928B1 (da) 2004-03-01
NL990011I1 (nl) 1999-07-01
AU613107B2 (en) 1991-07-25
EP0316633A1 (de) 1989-05-24
JPH10182464A (ja) 1998-07-07
IE61562B1 (en) 1994-11-16
JP2956029B2 (ja) 1999-10-04
YU46988B (sh) 1994-09-09
PT88985B (pt) 1993-01-29
JP3207816B2 (ja) 2001-09-10

Similar Documents

Publication Publication Date Title
BR8600428A (pt) Compostos heterociclicos,processo para sua preparacao,composicoes inseticidas,processo para combate a insetos daninhos,utilizacao e processo para a preparacao de composicoes
DE3875285D1 (de) Verwendung von salzen der n-acetylneuraminsaeure zur herstellung eines arzneimittels zum abschwellen der nasenschleimhaut.
PT91092A (pt) Processo para a preparacao de novos derivados de benzodiazepina
DK328888A (da) Bensothiaxolderivater
AU577928B2 (en) Labd-14-en-11-one derivatives
IL104943A0 (en) Xanthine derivatives and pharmaceutical compositions containing the same
ES8801189A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
ZA891493B (en) 4-substituted imidazole derivatives useful in perioperative care
NL930017I1 (nl) 1-(Cyclohexyl of cyclohexenyl)-4-aryl-4-piperidinecarbonzuurderivaten
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
AU4999785A (en) Low viscosity chromoglycate solutions
EP0260305A4 (en) CHINOLINYL ETHER TETRAZOLE AS A MEDIUM FOR TREATING HYPER-SENSITIVE DISEASES.
HUT41611A (en) Herbicides containing as active substance derivatives of phenil triazolinon and process for production of the active substance
ATE70180T1 (de) Aerosolmittel zur nasenverstaeubung von vitamin b 12.
PH25106A (en) 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof
AU6582186A (en) New aqueous emulsions of plant protection agents
FI882779A7 (fi) Menetelmä 4-(3,4-dikloorifenyyli)-4-fenyylibutaanihapon valmistamiseksi ja välituotteita
GB2168704B (en) 1-(tetrazol-5-ylphenyl)-2-(tetrazol-5-ylalkylthio) alcohols and their use as leukotriene antagonists
AU3145384A (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol N-substituted derivatives
BR8503988A (pt) Composicao fungicida,processo para obtencao de solucoes aquosas estaveis contendo"phosethyl-al"e processo para a protecao de culturas
ATE65022T1 (de) Konservierte augentropfen mit einem gehalt an cromoglycinsaeure.
ES295469U (es) Patilla para montura de gafas
ZA877454B (en) Therapeutic agent for the treatment of peptic ulcer disease
NO872874D0 (no) Amid-derivater.
FI892963A0 (fi) Farmaceutisk sammansaettning samt foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
8363 Opposition against the patent
V448 Application of spc

Free format text: PRODUCT NAME: AZELASTINHYDROCHLORID; REGISTRATION NO/DATE: 43763.00.00, 43765.00.00, 43766.00.00; 19981023

Spc suppl protection certif: 198 75 049

Filing date: 19981127

8331 Complete revocation
V454 Spc application withdrawn or to be regarded as withdrawn

Free format text: PRODUCT NAME: AZELASTINHYDROCHLORID; REGISTRATION NO/DATE: 43763.00.00, 43765.00.00, 43766.00.00; 19981023

Spc suppl protection certif: 198 75 049

Filing date: 19981127